On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs

Journal of Controlled Release

Volumn 170, Issue 3, 2013, Pages 358-364

  Bae, Hae Duck ^a   Lee, Kyunglim ^a  

^a Ewha Womans University   (South Korea)

Author keywords

(TCTP); Insulin; Nasal absorption; Protein transduction domain (PTD); TCTP PTD; Translationally controlled tumor protein

Indexed keywords

BACTERIOPHAGES; BIOCHEMISTRY; CHEMICAL BONDS; ENERGY TRANSFER; FLUORESCENCE; INSULIN; MACROMOLECULES; MAMMALS; TUMORS; VEHICLES;

(TCTP); FLUORESCENCE RESONANCE ENERGY TRANSFER MEASUREMENTS; HISTOLOGICAL EXAMINATION; MOLECULAR ASSOCIATIONS; NASAL ABSORPTION; PROTEIN TRANSDUCTION DOMAINS; RELATIVE PHARMACOLOGICAL BIOAVAILABILITIES; TCTP-PTD;

PROTEINS;

INSULIN; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENERGY TRANSFER; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSDUCTION DOMAIN;

INSULIN; NASAL ABSORPTION; PROTEIN TRANSDUCTION DOMAIN (PTD); TCTP-PTD; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN (TCTP);

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OLIGOPEPTIDES; PROTEIN STRUCTURE, TERTIARY; TRANSDUCTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84880183222     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.06.010     Document Type: Article

References (27)

1. P. Arora, S. Sharma, S. Garg, Permeability issues in nasal drug delivery, Drug Discov. Today 7 (2002) 967-975. (Pubitemid 35286901)
2. C. McMartin, LE. Hutchinson, R. Hyde, G.E. Peters, Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity, J. Pharm. Sci. 76 (1987) 535-540.
3. X. Duan, S. Mao, New strategies to improve the intranasal absorption of insulin, Drug Discov. Today 15 (2010) 416-427.
4. Y. Ozsoy, S. Gungor, E. Cevher, Nasal delivery of high molecular weight drugs, Molecules 14 (2009) 3754-3779.
5. S.G. Chandler, N.W. Thomas, L Illum, Nasal absorption in the rat III. Effect of lysophospholipids on insulin absorption and nasal histology, Pharm. Res. 11 (1994) 1623-1630. (Pubitemid 24339685)
6. E. Marttin, J.C. Verhoef, S.G. Romeijn, F.W. Merkus, Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity, Pharm. Res. 12 (1995) 1151-1157.
7. F.W.H.M. Merkus, N.G.M. Schipper, W.A.J.J. Hermens, S.G. Romeijn, J.C. Verhoef, Absorption enhancers in nasal drug delivery: efficacy and safety, J. Control. Release 24 (1993) 201-208. (Pubitemid 23161332)
8. P. Järver, U. Langel, The use of cell-penetrating peptides as a tool for gene regulation, Drug Discov. Today 9 (2004) 395-402. (Pubitemid 38479684)
9. M. Kim, H.Y. Kim, S. Kim, J. Jung, J. Maeng, J. Chang, K. Lee, A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells, Biomaterials 32 (2011) 222-230.
10. M.C. Morris, J. Depollier, J. Mery, F. Heitz, G. Divita, A peptide carrier for the delivery of biologically active proteins into mammalian cells, Nat. Biotechnol. 19 (2001) 1173-1176. (Pubitemid 33115705)
11. S.R. Schwarze, A. Ho, A. Vocero-Akbani, S.F. Dowdy, In vivo protein transduction: delivery of a biologically active protein into the mouse, Science 285 (1999) 1569-1572. (Pubitemid 29420581)
12. S. Khafagy el, M. Morishita, K. Isowa, J. Imai, K. Takayama, Effect of cell-penetrating peptides on the nasal absorption of insulin, J. Control. Release 133 (2009) 103-108.
13. J.F. Liang, V.C. Yang, Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency, Biochem. Biophys. Res. Commun. 335 (2005) 734-738. (Pubitemid 41188260)
14. M. Morishita, N. Kamei, J. Ehara, K. Isowa, K. Takayama, A novel approach using functional peptides for efficient intestinal absorption of insulin, J. Control. Release 118 (2007) 177-184. (Pubitemid 46329737)
15. M. Kim, J. Maeng, J. Jung, H.Y. Kim, H.J. Kim, Y. Kwon, K. Lee, Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein, Eur. J. Pharm. Sci. 43 (2011) 25-31.
16. Z. Shen, Q. Zhang, S. Wei, T. Nagai, Proteolytic enzymes as a limitation for pulmonary absorption of insulin: in vitro and in vivo investigations, Int. J. Pharm. 192 (1999) 115-121. (Pubitemid 29531546)
17. J.R. Lakowicz, Principles of Fluorescence Spectroscopy, second ed. Springer, New York, 1999.
18. S. Deshayes, K. Konate, G. Aldrian, L. Crombez, F. Heitz, G. Divita, Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake, Biochim. Biophys. Acta 1798 (2010) 2304-2314.
19. N. Kamei, M. Morishita, K. Takayama, Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides, J. Control. Release 136 (2009) 179-186.
20. S. Khafagy el, M. Morishita, K. Takayama, The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides, Int. J. Pharm. 388 (2010) 209-212.
21. A.R. Mendelsohn, R. Brent, Protein interaction methods-toward an endgame, Science 284 (1999) 1948-1950.
22. H.Y. Kim, S. Kim, H. Youn, J.K. Chung, D.H. Shin, K. Lee, The cell penetrating ability of the proapoptotic peptide KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH, Biomaterials 32 (2011) 5262-5268.
23. J. Lee, S. Kim, D.H. Shin, H.J. Kim, K. Lee, Neuroprotective effect of Cu, Zn-superoxide dismutase fused to a TCTP-derived protein transduction domain, Eur. J. Pharmacol. 666 (2011) 87-92.
24. S. Khafagy el, M. Morishita, N. Ida, R. Nishio, K. Isowa, K. Takayama, Structural requirements of penetratin absorption enhancement efficiency for insulin delivery, J. Control Release 143 (2010) 302-310.
25. R.J. England, J.J. Homer, L.C. Knight, S.R. Ell, Nasal pH measurement: a reliable and repeatable parameter, Clin. Otolaryngol Allied Sci. 24 (1999) 67-68. (Pubitemid 29116483)
26. M. Kaliner, Z. Marom, C. Patow, J. Shelhamer, Human respiratory mucus, J. Allergy Clin. Immunol. 73 (1984) 318-323. (Pubitemid 14164759)
27. N.G. Schipper, S. Olsson, J.A. Hoogstraate, A.G. deBoer, K.M. Varum, P. Artursson, Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement, Pharm. Res. 14 (1997) 923-929. (Pubitemid 27326989)